Disclaimer: This list is not inclusive of all medications used in HIV and AIDS therapies and is not intended for use in making clinical decisions. Contact a physician for the right medications for you.
Click on the links below to learn more about each medication.
HIV Protease Inhibitor (PI)
$7,994/yr., $666/month
HIV Protease Inhibitor (PI)
$6,280/yr., $523/month
HIV Protease Inhibitor (PI)
$8,011/yr., $668/month
HIV Protease Inhibitor (PI)
$8,125/yr., $677/month
HIV Protease Inihibitor (PI)
$8,910/yr., $743/month
HIV Protease Inhibitor (PI)
$8,381/yr., $698/month
Nucleoside analog (also called nucleoside reverse transcriptase inhibitor, NRTI or nuke)
$7,440/yr., $620/month
Nucleoside analog (also called nucleoside reverse transcriptase inhibitor, NRTI or nuke)
$3,435/yr., $286/month
Nucleoside analog (also called nucleoside reverse transcriptase inhibitor, NRTI or nuke)
$2,808/yr., $234/month
Nucleoside analog (also called nucleoside reverse transcriptase inhibitor, NRTI or nuke)
$4,013/yr., $334/month
Nucleoside analog (also called nucleoside reverse transcriptase inhibitor, NRTI or nuke)
$12,060/yr., $1,005/month
Nucleoside analog (also called nucleoside reverse transcriptase inhibitor, NRTI or nuke)
$3,420/yr., $285/month
Nucleoside analog (also called nucleoside reverse transcriptase inhibitor, NRTI or nuke)
$3,960/yr., $330/month
Nucleoside analog (also called nucleoside reverse transcriptase inhibitor, NRTI or nuke)
$4,615/yr., $384/month
Nucleotide analog (also called nucleotide reverse transcriptase inhibitor, NRTI or nuke)
$4,896/yr., $408/month
Non-nucleoside analog (also called non-nucleoside reverse transcriptase inhibitor, NRTI or non-nuke)
$3,504/yr., $292/month
Non-nucleoside analog (also called non-nucleoside reverse transcriptase inhibitor, NRTI or non-nuke)
$4,730/yr., $394/month
Non-nucleoside analog (also called non-nucleoside reverse transcriptase inhibitor, NRTI or non-nuke)
$3,826/yr., $319/month
Experimental fusion inhibitor
Not yet established because of experimental drug status
Experimental protease inhibitor
Not yet established because of experimental drug status